Global Paclitaxel Market 2017 by Players, Countries, Type and Application, Forecast to 2022

The Paclitaxel Research Report describe Industry Introduction, Product Scope, Market Overview, Opportunities, Market Risk, Driving Force. Global Market analyze by top manufacturers, by regions, by type and application. The report will include the qualitative and quantitative analysis with market estimation over 2018 – 2023 and compound annual growth rate (CAGR) between 2017 and 2022.

Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it “taxol”.

Scope of the Report:
This report focuses on the Paclitaxel in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Southpharma
Haiyao
Huiang biopharma
Yunnan Hande
Hainan Yew Pharm

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Natural Paclitaxel
Semi-synthetic Paclitaxel

Market Segment by Applications, can be divided into
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other

There are 15 Chapters to deeply display the global Paclitaxel market.

Chapter 1, to describe Paclitaxel Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Paclitaxel, with sales, revenue, and price of Paclitaxel, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Paclitaxel, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Paclitaxel market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Paclitaxel sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Table of Contents

1 Market Overview
1.1 Paclitaxel Introduction
1.2 Market Analysis by Type
1.2.1 Natural Paclitaxel
1.2.2 Semi-synthetic Paclitaxel
1.3 Market Analysis by Applications
1.3.1 Ovarian Cancer
1.3.2 Cervical Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Phyton
2.1.1 Business Overview
2.1.2 Paclitaxel Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Phyton Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 ScinoPharm
2.2.1 Business Overview
2.2.2 Paclitaxel Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 ScinoPharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novasep
2.3.1 Business Overview
2.3.2 Paclitaxel Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novasep Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Samyang
2.4.1 Business Overview
2.4.2 Paclitaxel Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Samyang Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Polymed
2.5.1 Business Overview
2.5.2 Paclitaxel Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Polymed Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 TAPI (Teva)
2.6.1 Business Overview
2.6.2 Paclitaxel Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 TAPI (Teva) Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Fresenius-kabi
2.7.1 Business Overview
2.7.2 Paclitaxel Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Fresenius-kabi Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Southpharma
2.8.1 Business Overview
2.8.2 Paclitaxel Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Southpharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Haiyao
2.9.1 Business Overview
2.9.2 Paclitaxel Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Haiyao Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Huiang biopharma
2.10.1 Business Overview
2.10.2 Paclitaxel Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Huiang biopharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Yunnan Hande
2.11.1 Business Overview
2.11.2 Paclitaxel Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Yunnan Hande Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Hainan Yew Pharm
2.12.1 Business Overview
2.12.2 Paclitaxel Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Hainan Yew Pharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Paclitaxel Market Competition, by Manufacturer
3.1 Global Paclitaxel Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Paclitaxel Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Paclitaxel Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Paclitaxel Manufacturer Market Share
3.4.2 Top 5 Paclitaxel Manufacturer Market Share
3.5 Market Competition Trend

4 Global Paclitaxel Market Analysis by Regions
4.1 Global Paclitaxel Sales, Revenue and Market Share by Regions
4.1.1 Global Paclitaxel Sales by Regions (2012-2017)
4.1.2 Global Paclitaxel Revenue by Regions (2012-2017)
4.2 North America Paclitaxel Sales and Growth (2012-2017)
4.3 Europe Paclitaxel Sales and Growth (2012-2017)
4.4 Asia-Pacific Paclitaxel Sales and Growth (2012-2017)
4.5 South America Paclitaxel Sales and Growth (2012-2017)
4.6 Middle East and Africa Paclitaxel Sales and Growth (2012-2017)

5 North America Paclitaxel by Countries, Type, Application and Manufacturers
5.1 North America Paclitaxel Sales, Revenue and Market Share by Countries
5.1.1 North America Paclitaxel Sales by Countries (2012-2017)
5.1.2 North America Paclitaxel Revenue by Countries (2012-2017)
5.1.3 USA Paclitaxel Sales and Growth (2012-2017)
5.1.4 Canada Paclitaxel Sales and Growth (2012-2017)
5.1.5 Mexico Paclitaxel Sales and Growth (2012-2017)
5.2 North America Paclitaxel Sales and Revenue (value) by Manufacturers (2016-2017)
5.2.1 North America Paclitaxel Sales by Manufacturers (2016-2017)
5.2.2 North America Paclitaxel Revenue by Manufacturers (2016-2017)
5.3 North America Paclitaxel Sales by Type (2012-2017)
5.4 North America Paclitaxel Sales by Application (2012-2017)

6 Europe Paclitaxel by Countries, Type, Application and Manufacturers
6.1 Europe Paclitaxel Sales, Revenue and Market Share by Countries
6.1.1 Europe Paclitaxel Sales by Countries (2012-2017)
6.1.2 Europe Paclitaxel Revenue by Countries (2012-2017)
6.1.3 Germany Paclitaxel Sales and Growth (2012-2017)
6.1.4 UK Paclitaxel Sales and Growth (2012-2017)
6.1.5 France Paclitaxel Sales and Growth (2012-2017)
6.1.6 Russia Paclitaxel Sales and Growth (2012-2017)
6.1.7 Italy Paclitaxel Sales and Growth (2012-2017)
6.2 Europe Paclitaxel Sales and Revenue (value) by Manufacturers (2016-2017)
6.2.1 Europe Paclitaxel Sales by Manufacturers (2016-2017)
6.2.2 Europe Paclitaxel Revenue by Manufacturers (2016-2017)
6.3 Europe Paclitaxel Sales by Type (2012-2017)
6.4 Europe Paclitaxel Sales by Application (2012-2017)

7 Asia-Pacific Paclitaxel by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Paclitaxel Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Paclitaxel Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Paclitaxel Revenue by Countries (2012-2017)
7.1.3 China Paclitaxel Sales and Growth (2012-2017)
7.1.4 Japan Paclitaxel Sales and Growth (2012-2017)
7.1.5 Korea Paclitaxel Sales and Growth (2012-2017)
7.1.6 India Paclitaxel Sales and Growth (2012-2017)
7.1.7 Southeast Asia Paclitaxel Sales and Growth (2012-2017)
7.2 Asia-Pacific Paclitaxel Sales and Revenue (value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Paclitaxel Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Paclitaxel Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Paclitaxel Sales by Type (2012-2017)
7.4 Asia-Pacific Paclitaxel Sales by Application (2012-2017)

8 South America Paclitaxel by Countries, Type, Application and Manufacturers
8.1 South America Paclitaxel Sales, Revenue and Market Share by Countries
8.1.1 South America Paclitaxel Sales by Countries (2012-2017)
8.1.2 South America Paclitaxel Revenue by Countries (2012-2017)
8.1.3 Brazil Paclitaxel Sales and Growth (2012-2017)
8.1.4 Argentina Paclitaxel Sales and Growth (2012-2017)
8.1.5 Columbia Paclitaxel Sales and Growth (2012-2017)
8.2 South America Paclitaxel Sales and Revenue (value) by Manufacturers (2016-2017)
8.2.1 South America Paclitaxel Sales by Manufacturers (2016-2017)
8.2.2 South America Paclitaxel Revenue by Manufacturers (2016-2017)
8.3 South America Paclitaxel Sales by Type (2012-2017)
8.4 South America Paclitaxel Sales by Application (2012-2017)

9 Middle East and Africa Paclitaxel by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Paclitaxel Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Paclitaxel Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Paclitaxel Revenue by Countries (2012-2017)
9.1.3 Saudi Arabia Paclitaxel Sales and Growth (2012-2017)
9.1.4 UAE Paclitaxel Sales and Growth (2012-2017)
9.1.5 Egypt Paclitaxel Sales and Growth (2012-2017)
9.1.6 Nigeria Paclitaxel Sales and Growth (2012-2017)
9.1.7 South Africa Paclitaxel Sales and Growth (2012-2017)
9.2 Middle East and Africa Paclitaxel Sales and Revenue (value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Paclitaxel Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Paclitaxel Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Paclitaxel Sales by Type (2012-2017)
9.4 Middle East and Africa Paclitaxel Sales by Application (2012-2017)

10 Global Paclitaxel Market Segment by Type
10.1 Global Paclitaxel Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Paclitaxel Sales and Market Share by Type (2012-2017)
10.1.2 Global Paclitaxel Revenue and Market Share by Type (2012-2017)
10.2 Natural Paclitaxel Sales Growth and Price
10.2.1 Global Natural Paclitaxel Sales Growth (2012-2017)
10.2.2 Global Natural Paclitaxel Price (2012-2017)
10.3 Semi-synthetic Paclitaxel Sales Growth and Price
10.3.1 Global Semi-synthetic Paclitaxel Sales Growth (2012-2017)
10.3.2 Global Semi-synthetic Paclitaxel Price (2012-2017)

11 Global Paclitaxel Market Segment by Application
11.1 Global Paclitaxel Sales Market Share by Application (2012-2017)
11.2 Ovarian Cancer Sales Growth (2012-2017)
11.3 Cervical Cancer Sales Growth (2012-2017)
11.4 Breast Cancer Sales Growth (2012-2017)
11.5 Other Sales Growth (2012-2017)

12 Paclitaxel Market Forecast (2017-2022)
12.1 Global Paclitaxel Sales, Revenue and Growth Rate (2017-2022)
12.2 Paclitaxel Market Forecast by Regions (2017-2022)
12.2.1 North America Paclitaxel Market Forecast (2017-2022)
12.2.2 Europe Paclitaxel Market Forecast (2017-2022)
12.2.3 Asia-Pacific Paclitaxel Market Forecast (2017-2022)
12.2.4 South America Paclitaxel Market Forecast (2017-2022)
12.2.5 Middle East and Africa Paclitaxel Market Forecast (2017-2022)
12.3 Paclitaxel Market Forecast by Type (2017-2022)
12.4 Paclitaxel Market Forecast by Application (2017-2022)

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source


Your Name (required)

Your Email (required)

Telephone Number (required)

Name of company (required)

Country Name (required)

How can we help you?